Infinity Pharmaceuticals Financials
| INFIQ Stock | 0.0001 0.00 0.00% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.68 | 3.4 |
|
|
The financial analysis of Infinity Pharmaceuticals is a critical element in measuring its lifeblood. Investors should not minimize Infinity Pharmaceuticals' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Infinity | Select Account or Indicator |
Understanding current and past Infinity Pharmaceuticals Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Infinity Pharmaceuticals' financial statements are interrelated, with each one affecting the others. For example, an increase in Infinity Pharmaceuticals' assets may result in an increase in income on the income statement.
Infinity Pharmaceuticals Stock Summary
Infinity Pharmaceuticals competes with Kaltura, VirnetX Holding, Qualys, Corporacion America, and Mesa Air. Infinity Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| Business Address | 1100 Massachusetts Avenue, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.infi.com |
| Phone | 617 453 1000 |
Infinity Pharmaceuticals Key Financial Ratios
| Operating Margin | (17.36) % | ||||
| Price To Sales | 0 X | ||||
| Revenue | 2.59 M | ||||
| Gross Profit | (31.38 M) | ||||
| EBITDA | (43.73 M) |
Infinity Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuticals competition to find correlations between indicators driving Infinity Pharmaceuticals's intrinsic value. More Info.Infinity Pharmaceuticals is currently regarded as number one stock in return on asset category among its peers. It also is currently regarded as number one stock in operating margin category among its peers . At this time, Infinity Pharmaceuticals' Operating Profit Margin is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Infinity Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Infinity Pharmaceuticals Systematic Risk
Infinity Pharmaceuticals' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Infinity Pharmaceuticals volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Infinity Pharmaceuticals correlated with the market. If Beta is less than 0 Infinity Pharmaceuticals generally moves in the opposite direction as compared to the market. If Infinity Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Infinity Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Infinity Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Infinity Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Infinity Pharmaceuticals is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Infinity has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Infinity Pharmaceuticals' financials are consistent with your investment objective using the following steps:- Review Infinity Pharmaceuticals' balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Infinity Pharmaceuticals' liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Infinity Pharmaceuticals' financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Infinity Pharmaceuticals' stock is overvalued or undervalued.
Today, most investors in Infinity Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Infinity Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Infinity Pharmaceuticals growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Additional Tools for Infinity Stock Analysis
When running Infinity Pharmaceuticals' price analysis, check to measure Infinity Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuticals is operating at the current time. Most of Infinity Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Infinity Pharmaceuticals' price. Additionally, you may evaluate how the addition of Infinity Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.